Sökning: "acute myocardial infarction. Biochemical markers"
Visar resultat 1 - 5 av 8 avhandlingar innehållade orden acute myocardial infarction. Biochemical markers.
1. Acute Myocardial Infarction: The Relationship between Duration of Ischaemia and Infarct Size in Humans - Assessment by MRI and SPECT
Sammanfattning : The effect of duration of ischaemia on final infarct size is well established in animal studies, but not fully evaluated in humans. Delayed contrast-enhanced magnetic resonance imaging (DE-MRI) can be used to distinguish between viable and non-viable myocardium and thus to quantify infarct size. LÄS MER
2. Artificial neural networks for assessment of patients with suspected acutemyocardial infarction
Sammanfattning : An early diagnosis within the first hours after onset of symptoms is essential for the optimal treatment of patients admitted with chest pain of suspected cardiac origin. In the majority of patients, the 12-lead ECG is nondiagnostic on admission. LÄS MER
3. Cardiac Troponins in Patients with Suspected or Confirmed Acute Coronary Syndrome : New Applications for Biomarkers in Coronary Artery Disease
Sammanfattning : The cardiac troponins are the biochemical markers of choice for the diagnosis of acute myocardial infarction (AMI) and risk prediction in patients with acute coronary syndrome (ACS). In this thesis, the role of early serial cardiac troponin I (cTnI) testing was assessed in fairly unselected patient populations admitted because of chest pain and participating in the FAST II-study (n=197) and the FASTER I-study (n=380). LÄS MER
4. Evaluation of risk factor modification management in patients with coronary heart disease and patients´ experiences of secondary prevention
Sammanfattning : Aim: To evaluate management of risk factor modification among patients suffering from coronary heart disease and to explore patients experiences of secondary prevention. Methods: After establishing a secondary prevention programme, patients were offered follow-up visits to a nurse, one year after the coronary event for evaluation of various risk factors associated with recurrence (I, II). LÄS MER
5. Targeted multiplex proteomics for risk stratification in patients with cardiovascular disease
Sammanfattning : Risk stratification is valuable in patients with cardiovascular disease (CVD). Proteins involved in different pathophysiological processes in atherosclerosis have shown prognostic capacity. A new technology, Proximity Extension Assay (PEA), enables the simultaneous analysis of numerous plasma proteins from a minimal amount of plasma. LÄS MER